Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC Webster TX 77598 USA

UEI: SLED_180634E2C8E4D567

TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC Webster TX 77598 USA is a federal contractor, registered under UEI SLED_180634E2C8E4D567. It has been awarded $50,000,000 across 1 federal contract. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology). Top awarding agencies include FDA Office Of Acq Grant Svcs.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_180634E2C8E4D567

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

FDA Office Of Acq Grant Svcs$50.0M100%

Awards by NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)$50.0M100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC Webster TX 77598 USA's top NAICS codes and agencies

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Solicitation # W911SR-26-R-HEAL

The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.

POSTED

DEADLINE

Post-warranty Preventive Maintenance and Repair Services on a Perkin Elmer Hyphenated Thermogravimetric Analyzer with Fourier Transformed Infrared Spectroscopy-Gas Chromatography-Mass spectrometer (TGA-FTIR-GCMS) System

Solicitation # 75F40126Q133960

Solicitation 75F40126Q133960 is a combined, firm-fixed-price commercial item contract issued by the FDA Office of Acquisition and Grant Services for post-warranty preventive maintenance and repair services on a Perkin Elmer TGA-FTIR-GCMS system. The work will be performed at the FDA/NCTR facility in Jefferson, Arkansas, and includes annual on-site preventive maintenance, unlimited corrective repairs with a three-business-day response time, and continuous technical support. Services must be performed by OEM-certified engineers using original parts and manuals. The period of performance consists of a base year from September 1, 2026, to August 31, 2027, with two optional one-year extensions, for a total potential duration of three years. The award will be based on a best-value trade-off methodology, prioritizing technical capability and past performance over price. Offerors must submit their proposals via email to Warren Dutter by the amended deadline of August 20, 2026, at 1:00 PM Central Time. Required documentation includes a detailed technical approach, verifiable experience, and a Voluntary Product Accessibility Template for Section 508 compliance. All submissions must be macro-free. Contract administration requires the use of the Treasury's Invoice Processing Platform for electronic payments with net 30-day terms. The contract is open for full competition under NAICS code 811210, with a price evaluation preference available for HUBZone small businesses.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Validation and Optimization of ONE-STEP Tagging in Human induced Pluripotent Stem Cells

Solicitation # NIH-NOI-PCA-NIA-01590

The National Institute on Aging (NIA), under the National Institutes of Health (NIH) and Department of Health and Human Services (HHS), has issued a Notice of Intent to Sole Source for the validation and optimization of ONE-STEP tagging in human induced pluripotent stem cells (iPSCs). This acquisition aims to support the iPSC Neurodegenerative Disease Initiative (iNDI) and the Center of Alzheimer’s Disease and Related Dementias (CARD) by generating functionally engineered iPSC lines for research into Alzheimer’s disease and related dementias. The project involves high-activity guide identification, Bxb1 mRNA and cargo plasmid delivery optimization, and the generation of ADRD variant, MAPT 4R, and wild-type process-control clones. All deliverables must be repository-ready, meeting strict quality control standards including long-read sequencing, karyotype analysis, and SNP arrays to ensure scientific continuity and data integrity. The government intends to award this contract to The Jackson Laboratory, citing them as the only responsible source capable of meeting the requirements under FAR 6.302-1 and FAR 13.501(a). This determination is based on the laboratory's unique continuity with the existing iNDI program, established workflows for specific background lines, and proven success in large-scale CRISPR/Cas9 engineering. The total estimated contract value is 3,353,115.00 dollars, covering a base year from September 1, 2026, to August 31, 2027, and an option year extending to August 31, 2028. While this is a sole-source intent, the government will consider capability statements from other sources submitted by August 21, 2026, to determine if adequate competition exists.

National Institutes Of Health Olao

POSTED

DEADLINE

Sole Source - Production of ChAdOx-1 and MVA expressing mouse gp70

Solicitation # 75N98026Q00996

The National Cancer Institute intends to award a sole-source, firm fixed price contract under solicitation RFQ 75N98026Q00996 to the Viral Vector Core at the Pandemic Institute, University of Oxford. The project involves the design and production of ChAdOx-1 and MVA viral vectors expressing mouse gp70 and the mouse class II major histocompatibility complex invariant chain. This research is critical for evaluating vaccine efficacy against breast cancer brain metastasis, utilizing proprietary chimpanzee adenovirus technology to avoid pre-existing human adenovirus immunity. The contract falls under NAICS code 541714 for biotechnology research and development and has a performance period of six months from the date of award. Payment terms are set at net 30 days following the acceptance of deliverables. While intended as a sole-source procurement due to the proprietary nature of the technology, the agency will consider capability statements from other interested parties submitted by August 24, 2026.

POSTED

DEADLINE

Core Research in Biological Sciences (BIO Core)

Solicitation # 26-517

The National Science Foundation's Directorate for Biological Sciences is offering funding through the Core Research in Biological Sciences solicitation 26-517. This opportunity supports foundational and interdisciplinary research across all biological levels, from molecular to biome scales, encompassing both legacy program topics and new areas of biological science. The program provides single- and multi-investigator awards with flexible budgets and durations to accommodate both small exploratory projects and long-term research commitments. These federal awards are subject to the availability of funds and are managed by the National Science Foundation.

National Science Foundation

POSTED

DEADLINE

in almost 50 years

On-Site Installation and Training ServicesThis subcontract opportunity with the Department of Commerce NIST involves on-site installation, calibration, and training services located in Gaithersburg, Maryland. The scope of work includes system setup and the verification of technical specifications. While these specific services are not mandatory, they will be given additional evaluation consideration if included in the proposal. The project is designated as a total Small Business Set Aside under NAICS code 541714. Interested parties must submit their responses by August 28, 2026, at 1:00 PM. The solicitation was officially posted on August 15, 2026.

Department Of Commerce Nist

POSTED

DEADLINE

Calibration and Performance Verification ServicesThis subcontract, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, focuses on the post-installation calibration and performance validation of incubation chambers. The primary objective is to ensure that these chambers comply with USP standards for temperature stability and uniformity. The project is categorized under NAICS code 541380 and will be performed in Jamaica. Interested parties must submit their responses by August 21, 2026, following the posting date of August 14, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Delivery and Installation Services for Lab EquipmentThis subcontract involves the delivery and installation of two sensitive environmental incubator chambers at an FDA facility located in Jamaica, New York. The project is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, falling under NAICS code 484121. The scope of work requires the contractor to handle the transportation and setup of the lab equipment while ensuring full coordination with FDA staff and strict adherence to site access compliance protocols. The solicitation was posted on August 14, 2026, with a response deadline set for August 21, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Supply of Environmental Incubator ChambersThe Department of Health and Human Services, through the FDA Office of Acquisition and Grant Services, is seeking a subcontractor for the procurement and delivery of two Thermo Scientific Heratherm Environmental Incubation Chambers. These units must adhere to strict performance and regulatory standards to support FDA microbiological testing. The contract is categorized under NAICS code 334516 and will be performed in Jamaica. Interested parties must submit their responses by August 21, 2026, following the posting date of August 14, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Subcontract Management and Flowdown ComplianceThe Subcontract Management and Flowdown Compliance contract, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, focuses on the administration of subcontractor agreements. The primary objective is to ensure the proper flowdown of mandatory Federal Acquisition Regulation clauses, specifically those concerning cybersecurity, data rights, and the protection of personally identifiable information, while maintaining rigorous ongoing compliance monitoring. This subcontract opportunity is categorized under NAICS code 541611 and will be performed in Silver Spring. Interested parties must submit their responses by the deadline of August 31, 2026, following the posting date of August 14, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Cybersecurity and CUI Compliance SupportThe Cybersecurity and CUI Compliance Support subcontract, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, focuses on ensuring that all software and documentation adhere to strict federal security standards. Specifically, the contractor must maintain compliance with NIST SP 800-171 for the handling of Controlled Unclassified Information and NIST SP 800-88 for proper media sanitization, while also meeting all necessary incident reporting requirements. This opportunity falls under NAICS code 541512 and is based in Silver Spring. Interested parties must submit their responses by August 31, 2026, following the posting date of August 14, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Version Control and DevOps SupportThe Version Control and DevOps Support subcontract, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, focuses on enhancing software maintainability and sustainability. The primary objective is the implementation of Git-based version control, repository management, and the establishment of CI/CD pipelines. This opportunity is categorized under NAICS code 541511 and is set to be performed in Silver Spring. The solicitation was posted on August 14, 2026, with a response deadline of August 31, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Technical Documentation and Scientific WritingThis subcontract opportunity with the FDA Office of Acquisition and Grant Services involves the production of comprehensive technical documentation and scientific writing. The scope of work requires the creation of user manuals, API guides, and validation reports delivered in a searchable PDF format and aligned with FAIR data principles. The project is categorized under NAICS code 541930 and will be performed in Silver Spring. Interested parties must submit their responses by August 31, 2026, following the posting date of August 14, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Software Testing and Quality Assurance (QA)This subcontract for Software Testing and Quality Assurance is issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The project focuses on executing unit, integration, and regression testing to verify that software meets strict performance and accuracy standards, specifically requiring a focal location error of less than 2 mm and a total computation time of under 16 hours. The opportunity was posted on August 14, 2026, with a response deadline of August 31, 2026. The work is categorized under NAICS code 541512 and is designated for performance in Silver Spring.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Cross-Platform GUI and Command-Line Interface DevelopmentThis subcontract opportunity with the FDA Office of Acquisitions and Grant Services involves the design and implementation of both a graphical user interface and a command-line interface for an ultrasound modeling tool. A primary requirement of the project is to ensure full cross-platform compatibility across Windows, Linux, and macOS operating systems. The project is managed under NAICS code 541512 and is based in Silver Spring. Interested parties must submit their responses by August 31, 2026, following the posting date of August 14, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Computational Modeling Software DevelopmentThis subcontract, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, focuses on the development of an open-source computational modeling package. The primary objective is to simulate transcranial ultrasound sonication utilizing validated numerical methods, specifically FDTD or PSTD. The project is categorized under NAICS code 541715 and will be performed in Silver Spring. Interested parties must submit their responses by August 31, 2026, following the posting date of August 14, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Sustainable Procurement of Supplies and ServicesThe Sustainable Procurement of Supplies and Services subcontract, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, focuses on the delivery of products and services that adhere to strict sustainable procurement standards. All deliverables must comply with clause 52.223-23, requiring the use and documentation of energy-efficient, recyclable, or environmentally preferable materials. This opportunity is categorized under NAICS code 541611 and is to be performed in Silver Spring, Maryland. The solicitation was posted on August 14, 2026, with a response deadline of August 21, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Section 508 Accessibility Compliance for ICT DeliverablesThis subcontract opportunity with the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services focuses on ensuring that all ICT products and associated documentation adhere to Section 508 accessibility standards. The selected provider will be responsible for the preparation and submission of Voluntary Product Accessibility Templates and HHS Accessibility Conformance Reports. The project is based in Silver Spring, Maryland, and falls under NAICS code 541618. Interested parties must submit their responses by August 21, 2026, following the posting date of August 14, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE